| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2867729
[patent_doc_number] => 05162344
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-11-10
[patent_title] => 'Procaine double salt complexes'
[patent_app_type] => 1
[patent_app_number] => 7/322917
[patent_app_country] => US
[patent_app_date] => 1989-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3994
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/162/05162344.pdf
[firstpage_image] =>[orig_patent_app_number] => 322917
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/322917 | Procaine double salt complexes | Mar 13, 1989 | Issued |
Array
(
[id] => 2705977
[patent_doc_number] => 05001117
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-03-19
[patent_title] => 'Use of lecithin to restore olfaction and taste'
[patent_app_type] => 1
[patent_app_number] => 7/319744
[patent_app_country] => US
[patent_app_date] => 1989-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1960
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/001/05001117.pdf
[firstpage_image] =>[orig_patent_app_number] => 319744
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/319744 | Use of lecithin to restore olfaction and taste | Mar 6, 1989 | Issued |
| 07/318985 | LYOPHILIZED BMY-28142 DIHYDROCHLORIDE FOR PARENTERAL USE | Mar 5, 1989 | Abandoned |
Array
(
[id] => 2596741
[patent_doc_number] => 04975426
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-12-04
[patent_title] => 'Cough/cold mixtures comprising non-sedating antihistamine drugs'
[patent_app_type] => 1
[patent_app_number] => 7/315161
[patent_app_country] => US
[patent_app_date] => 1989-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3504
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/975/04975426.pdf
[firstpage_image] =>[orig_patent_app_number] => 315161
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/315161 | Cough/cold mixtures comprising non-sedating antihistamine drugs | Feb 23, 1989 | Issued |
| 07/314766 | XYLITOL-BASED BINDING AND DILUTING AGENT AND A PROCESS FOR THE PRODUCTION THEREOF | Feb 22, 1989 | Abandoned |
| 07/312730 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Feb 16, 1989 | Abandoned |
Array
(
[id] => 2652785
[patent_doc_number] => 04929437
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-05-29
[patent_title] => 'Coenzyme Q.sub.10 with HMG-CoA reductase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 7/305140
[patent_app_country] => US
[patent_app_date] => 1989-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 879
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/929/04929437.pdf
[firstpage_image] =>[orig_patent_app_number] => 305140
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/305140 | Coenzyme Q.sub.10 with HMG-CoA reductase inhibitors | Feb 1, 1989 | Issued |
Array
(
[id] => 2563865
[patent_doc_number] => 04945083
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-07-31
[patent_title] => 'Safe oral folic-acid-containing vitamin preparation'
[patent_app_type] => 1
[patent_app_number] => 7/305422
[patent_app_country] => US
[patent_app_date] => 1989-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2308
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/945/04945083.pdf
[firstpage_image] =>[orig_patent_app_number] => 305422
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/305422 | Safe oral folic-acid-containing vitamin preparation | Jan 31, 1989 | Issued |
Array
(
[id] => 2669184
[patent_doc_number] => 05070080
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-12-03
[patent_title] => 'Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form'
[patent_app_type] => 1
[patent_app_number] => 7/303747
[patent_app_country] => US
[patent_app_date] => 1989-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4272
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/070/05070080.pdf
[firstpage_image] =>[orig_patent_app_number] => 303747
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/303747 | Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form | Jan 29, 1989 | Issued |
| 07/303536 | MAGNESIUM POTASSIUM CITRATE | Jan 26, 1989 | Abandoned |
Array
(
[id] => 2583856
[patent_doc_number] => 04908202
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-03-13
[patent_title] => 'Use of 2-oxo-1-pyrrolidineacetamide for the determination of the glomerular filtration rate in humans'
[patent_app_type] => 1
[patent_app_number] => 7/299793
[patent_app_country] => US
[patent_app_date] => 1989-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1361
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/908/04908202.pdf
[firstpage_image] =>[orig_patent_app_number] => 299793
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/299793 | Use of 2-oxo-1-pyrrolidineacetamide for the determination of the glomerular filtration rate in humans | Jan 22, 1989 | Issued |
Array
(
[id] => 2589965
[patent_doc_number] => 04933165
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-06-12
[patent_title] => 'Coenzyme Q.sub.10 with HMG-CoA reductase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 7/298535
[patent_app_country] => US
[patent_app_date] => 1989-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 956
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/933/04933165.pdf
[firstpage_image] =>[orig_patent_app_number] => 298535
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/298535 | Coenzyme Q.sub.10 with HMG-CoA reductase inhibitors | Jan 17, 1989 | Issued |
| 07/295113 | PROCESS FOR ENHANCING WOUND HEALING | Jan 8, 1989 | Abandoned |
Array
(
[id] => 2739936
[patent_doc_number] => 05028439
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-07-02
[patent_title] => 'Inhibition of parathyroid hormone secretion'
[patent_app_type] => 1
[patent_app_number] => 7/296390
[patent_app_country] => US
[patent_app_date] => 1989-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2010
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/028/05028439.pdf
[firstpage_image] =>[orig_patent_app_number] => 296390
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/296390 | Inhibition of parathyroid hormone secretion | Jan 8, 1989 | Issued |
| 07/318591 | COMPOSITION HAVING REDUCED NEPHROTOXICITY COMPRISING A FATTY ACID CONTAINING COMPONENT AND CYCLOSPORINE | Dec 29, 1988 | Abandoned |
| 07/287974 | COMPOSITIONS AND METHODS FOR IMPROVING COLD TOLERANCE IN ANIMALS AND HUMANS | Dec 19, 1988 | Abandoned |
Array
(
[id] => 2734272
[patent_doc_number] => 05032608
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-07-16
[patent_title] => 'Method and substrate composition for treating atherosclerosis'
[patent_app_type] => 1
[patent_app_number] => 7/287620
[patent_app_country] => US
[patent_app_date] => 1988-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8145
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/032/05032608.pdf
[firstpage_image] =>[orig_patent_app_number] => 287620
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/287620 | Method and substrate composition for treating atherosclerosis | Dec 15, 1988 | Issued |
| 07/284933 | TOPICAL FORMULATIONS AND TRANSDERMAL DELIVERY SYSTEMS CONTAINING 1-ISOBUTYL-1H-IMIDAZO(4,5-C)QUINOLINE-4-AMINE | Dec 14, 1988 | Abandoned |
| 07/284505 | DERIVATIVES OF 5-HYDROXY AND 5-METHOXY 2-AMINO-PYRIMIDINES AS INHIBITORS OF INTERLEUKIN-1 PRODUCTION | Dec 13, 1988 | Abandoned |
| 07/282647 | COMBINATION OF AN HMG COA REDUCTASE INHIBITOR AND OTHER TYPE O SERUM CHOLESTEROL REDUCING AGENT AND METHOD FOR LOWERING SERUM CHOLESTEROL USING SUCH COMBINATION | Dec 11, 1988 | Abandoned |